61440-60-6

Basic information

• Product Name: 3-(4-chlorophenyl)propyl methanesulfonate
• Synonyms: 3-(4-chlorophenyl)propyl methanesulfonate;-(4-chlorophenyl)propyl methanesulfonate
• CAS NO: 61440-60-6
• Molecular Formula: C₁₀H₁₃ClO₃S
• Molecular Weight: 248.73
• Mol File: 61440-60-6.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(4-chlorophenyl)propyl methanesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-chlorophenyl)propyl methanesulfonate(61440-60-6)
• EPA Substance Registry System: 3-(4-chlorophenyl)propyl methanesulfonate(61440-60-6)

Safety Data

• Hazardous Substances Data: 61440-60-6(Hazardous Substances Data)

Usage

Uses

3-(4-Chlorophenyl)propyl Mesylate is a useful reagent in the synthesis of Tiprolisant; a medication for the treatment of excessive daytime sleepiness in adults with narcolepsy.

Upstream product

• 6282-88-8 3-(p-chlorophenyl)propanol 
• 2019-34-3 3-(4-chlorophenyl)propanoic acid 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 96089-75-7 4-[bis[3-(p-chlorophenyl)propyl]amino]benzoic acid, ethyl ester 
• 61440-61-7 ethyl 4-[3-(p-chlorophenyl)propylamino]benzoate 
• 362665-56-3 pitolisant 
• 756836-89-2 4-carboxy-2-[3-(4-chlorophenyl)propyl]-6-(2,3-dihydro-1-benzofuran-5-yl)-2H-pyridazin-3-one 
• 175219-66-6 S-[3-(4-chlorophenyl)propyl]ethanethioate 
• 294863-07-3 1-{(R)-1-(tert-butyldimethylsilyloxy)-4-[5-(3-(4-chlorophenyl)propoxy)-1-methylindol-3-yl]-2-butyl}imidazole-4-carboxamide 
• 294863-03-9 1-[(R)-1-(tert-butyldimethylsilyloxy)-4-[6-(3-(4-chlorophenyl)propoxy)indol-1-yl]-2-butyl]imidazole-4-carboxamide 

Relevant articles and documents

DEUTERATED PITOLISANT

This invention also provides compound of Formula (I) including pharmaceutical compositions comprising a compound of Formula (I) and a pharmaceutically acceptable carrier. This invention also provides the use of such compounds and compositions in methods o

A new series of estrogen receptor modulators that display selectivity for estrogen receptor β

A series of 1,3,5-triazine-based estrogen receptor (ER) modulators that are modestly selective for the ERβ subtype are reported. Compound 1, which displayed modest potency and selectivity for ERβ vs ERα, was identified via high-throughput screening utiliz

Arylalkylaminobenzoic acids

This disclosure describes novel [Bis(phenyl or substituted phenyl)alkyl]amino benzoic acids, esters, and derivatives thereof. These compounds are useful pharmaceutical agents for ameliorating atherosclerosis by inhibiting the formation and development of atherosclerotic lesions in the arterial walls of mammals.